- Home
- NTRB vs MGRM Comparison
NTRB vs MGRM Comparison
Compare NTRB & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- MGRM
- Stock Information
- Founded
- NTRB 2016
- MGRM 2016
- Country
- NTRB United States
- MGRM United States
- Employees
- NTRB N/A
- MGRM N/A
- Industry
- NTRB Industrial Specialties
- MGRM Medical/Dental Instruments
- Sector
- NTRB Health Care
- MGRM Health Care
- Exchange
- NTRB Nasdaq
- MGRM Nasdaq
- Market Cap
- NTRB 77.9M
- MGRM 73.5M
- IPO Year
- NTRB N/A
- MGRM N/A
- Fundamental
- Price
- NTRB $4.73
- MGRM $2.05
- Analyst Decision
- NTRB
- MGRM
- Analyst Count
- NTRB 0
- MGRM 0
- Target Price
- NTRB N/A
- MGRM N/A
- AVG Volume (30 Days)
- NTRB 18.3K
- MGRM 122.7K
- Earning Date
- NTRB 12-11-2024
- MGRM 11-14-2024
- Dividend Yield
- NTRB N/A
- MGRM N/A
- EPS Growth
- NTRB N/A
- MGRM N/A
- EPS
- NTRB N/A
- MGRM N/A
- Revenue
- NTRB $1,803,816.00
- MGRM $364,999.00
- Revenue This Year
- NTRB N/A
- MGRM N/A
- Revenue Next Year
- NTRB N/A
- MGRM N/A
- P/E Ratio
- NTRB N/A
- MGRM N/A
- Revenue Growth
- NTRB N/A
- MGRM N/A
- 52 Week Low
- NTRB $2.09
- MGRM $1.53
- 52 Week High
- NTRB $9.60
- MGRM $4.90
- Technical
- Relative Strength Index (RSI)
- NTRB 35.59
- MGRM 33.38
- Support Level
- NTRB $4.63
- MGRM $2.25
- Resistance Level
- NTRB $5.33
- MGRM $2.23
- Average True Range (ATR)
- NTRB 0.39
- MGRM 0.14
- MACD
- NTRB -0.13
- MGRM -0.02
- Stochastic Oscillator
- NTRB 5.65
- MGRM 18.18
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.